251 related articles for article (PubMed ID: 17521052)
1. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
Benko A; Fraser-Hill M; Magner P; Capusten B; Barrett B; Myers A; Owen RJ;
Can Assoc Radiol J; 2007 Apr; 58(2):79-87. PubMed ID: 17521052
[TBL] [Abstract][Full Text] [Related]
2. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.
Owen RJ; Hiremath S; Myers A; Fraser-Hill M; Barrett BJ
Can Assoc Radiol J; 2014 May; 65(2):96-105. PubMed ID: 24559602
[TBL] [Abstract][Full Text] [Related]
3. [Iodinated contrast agent-induced nephropathy].
Erley C
Radiologe; 2007 Sep; 47(9):761-7. PubMed ID: 17823784
[TBL] [Abstract][Full Text] [Related]
4. Current concepts of contrast-induced nephropathy: a brief review.
Chang CF; Lin CC
J Chin Med Assoc; 2013 Dec; 76(12):673-81. PubMed ID: 24090599
[TBL] [Abstract][Full Text] [Related]
5. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
[TBL] [Abstract][Full Text] [Related]
6. Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.
Busch SV; Jensen SE; Rosenberg J; Gögenur I
J Interv Cardiol; 2013 Feb; 26(1):97-105. PubMed ID: 23240788
[TBL] [Abstract][Full Text] [Related]
7. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of contrast-induced acute kidney injury].
Guastoni C; De Servi S; Covella P; Turri C; Gidaro B; Bellotti N; Stasi A
G Ital Nefrol; 2012; 29 Suppl 58():S33-45. PubMed ID: 23229601
[TBL] [Abstract][Full Text] [Related]
9. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
van der Molen AJ; Reimer P; Dekkers IA; Bongartz G; Bellin MF; Bertolotto M; Clement O; Heinz-Peer G; Stacul F; Webb JAW; Thomsen HS
Eur Radiol; 2018 Jul; 28(7):2856-2869. PubMed ID: 29417249
[TBL] [Abstract][Full Text] [Related]
10. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
11. Contrast-induced nephropathy--prevention and risk reduction.
Lameire NH
Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.
Wu MY; Hsiang HF; Wong CS; Yao MS; Li YW; Hsiang CY; Bai CH; Hsu YH; Lin YF; Tam KW
Int Urol Nephrol; 2013 Oct; 45(5):1309-18. PubMed ID: 23283594
[TBL] [Abstract][Full Text] [Related]
14. Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report.
Kim SM; Cha RH; Lee JP; Kim DK; Oh KH; Joo KW; Lim CS; Kim S; Kim YS
Am J Kidney Dis; 2010 Jun; 55(6):1018-25. PubMed ID: 20097462
[TBL] [Abstract][Full Text] [Related]
15. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
[TBL] [Abstract][Full Text] [Related]
16. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
[TBL] [Abstract][Full Text] [Related]
17. [Contrast induced nephropathy].
Hörl WH
Wien Klin Wochenschr; 2009; 121(1-2):15-32. PubMed ID: 19263010
[TBL] [Abstract][Full Text] [Related]
18. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Reinecke H; Fobker M; Wellmann J; Becke B; Fleiter J; Heitmeyer C; Breithardt G; Hense HW; Schaefer RM
Clin Res Cardiol; 2007 Mar; 96(3):130-9. PubMed ID: 17180572
[TBL] [Abstract][Full Text] [Related]
20. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]